Financial Partners Capital Management LLC Biogen Inc. Transaction History

Financial Partners Capital Management LLC

  • $449 Billion
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Feb 27, 2023
SELL
$282.99 - $369.05 $182,811 - $238,406
-646 Closed
0 $0
Q2 2021

Feb 27, 2023
BUY
$259.0 - $414.71 $167,314 - $267,902
646 New
646 $223,000
Q3 2020

Feb 28, 2023
SELL
$264.77 - $305.71 $174,483 - $201,462
-659 Closed
0 $0
Q1 2020

Feb 28, 2023
BUY
$268.85 - $341.04 $177,172 - $224,745
659 New
659 $208,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.6B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Financial Partners Capital Management LLC Portfolio

Follow Financial Partners Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Partners Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Partners Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email